By acting on soluble IL-6R, monoclonal antibodies might also affect the signalling of IL-27p28/IL-30, possibly interfering with the induction of CXCL10 (31), another chemokine that is strongly upregulated in COVID-19 (7). The gene discussed is IL6R; the disease is COVID-19.